Article
Repurposing the dopamine transporter antagonist vanoxerine to treat colorectal cancer - Nature Cancer
Rating:
0.0
Views:
21
Likes:
1
Library:
1
Self-renewing cancer stem cells drive tumor initiation and progression and represent a major target for therapeutic development. A study now shows that vanoxerine, a dopamine transporter antagonist, precisely inhibits this cell population in colorectal cancer, which leads to attenuation of tumor initiation and increased infiltration by immune cells.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value